Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: RETRACTED ARTICLE: Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer

Figure 6

ELISA assays of the IFN-β (A), TNF-α (B), IL-6 (C), and IL-8(D) levels. Supernatants of ovarian samples (n = 20/group) displaying papillary carcinoma were assessed 60 days after the final dose of mel. aP < 0.01 vs. OC. IFN-β: interferon-β; TNF-α: tumor necrosis factor alpha; IL-6: interleukin-6; IL-8: interleukin-8. All results are expressed as the means ± SD. Two-way ANOVA followed by Tukey test was performed.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us